(Q34133868)

English

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

David F. Penson

object named as

David F Penson

2

0 references

Stephen K Van Den Eeden

5

object named as

Stephen K Van Den Eeden

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Huei-Ting Tsai

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kepher H Makambi

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

John H Lynch

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Arnold L Potosky

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

327-333

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Intermittent androgen suppression for rising PSA level after radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 July 2018

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 July 2018

Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 July 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 July 2018

The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Androgen suppression strategies for prostate cancer: is there an ideal approach?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Continuous versus six months a year maximal androgen blockade in the management of prostate cancer: a randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Intermittent Androgen Deprivation for Patients With Recurrent/Metastatic Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154705

28 October 2018

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.078

7 January 2021

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.078

7 January 2021

Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.078

7 January 2021

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.078

7 January 2021

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.078

7 January 2021

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23896094

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent androgen deprivation therapy: redefining the standard of care?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23896094

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.UROLOGY.2013.01.078

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

release_qxmkeuruyvgrxbtewboje3zoyi

1 reference

https://api.fatcat.wiki/v0/release/qxmkeuruyvgrxbtewboje3zoyi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34133868&oldid=1869338857"